Unlock Premium for Just $9.99/Month – Special Launch Offer, Limited Time Only
Get Premium
PFE Pfizer Inc
- Stocks
- Healthcare
- NYSE: PFE
Price (delayed)
$25.38
Market cap
$144.29B
P/E Ratio
18.26
Dividend/share
$1.7
EPS
$1.39
Enterprise value
$204.97B
Pfizer Inc. is an American multinational pharmaceutical corporation. It is one of the world's largest pharmaceutical companies and ranked 57 on the 2018 Fortune 500 list of the largest United
Highlights
The quick ratio has grown by 40% YoY and by 8% from the previous quarter
Pfizer's gross profit has increased by 39% YoY
Pfizer's equity has increased by 2.4% QoQ but it has decreased by 2.1% YoY
Pfizer's EPS has decreased by 2.1% from the previous quarter
Key stats
What are the main financial stats of PFE
Market
Valuations
Earnings
Shares outstanding
5.69B
Market cap
$144.29B
Enterprise value
$204.97B
Price to earnings (P/E)
18.26
Price to book (P/B)
1.59
Price to sales (P/S)
2.31
EV/EBIT
27.8
EV/EBITDA
14.37
EV/Sales
3.28
Revenue
$62.46B
Gross profit
$45.15B
Operating income
$7.39B
Net income
$7.88B
EBIT
$7.37B
EBITDA
$14.27B
Free cash flow
$11.22B
Per share
Balance sheet
Liquidity
EPS
$1.39
EPS diluted
$1.38
Free cash flow per share
$1.98
Book value per share
$15.94
Revenue per share
$11.01
TBVPS
$15.09
Total assets
$208.03B
Total liabilities
$117.39B
Debt
$62.11B
Equity
$90.34B
Working capital
$9.41B
Debt to equity
0.69
Current ratio
1.26
Quick ratio
0.8
Net debt/EBITDA
4.25
Margins
Efficiency
Dividend
EBITDA margin
22.8%
Gross margin
72.3%
Net margin
12.6%
Operating margin
11.8%
Return on assets
3.7%
Return on equity
8.8%
Return on invested capital
6.6%
Return on capital employed
4.3%
Return on sales
11.8%
Dividend yield
6.7%
DPS
$1.7
Payout ratio
122.3%
PFE stock price
How has the Pfizer stock price performed over time
Intraday
0.24%
1 week
4.7%
1 month
8.69%
1 year
-8.38%
YTD
-4.33%
QTD
4.7%
Financial performance
How have Pfizer's revenue and profit performed over time
Revenue
$62.46B
Gross profit
$45.15B
Operating income
$7.39B
Net income
$7.88B
Gross margin
72.3%
Net margin
12.6%
Pfizer's gross profit has increased by 39% YoY
The gross margin has grown by 24% YoY
Pfizer's revenue has increased by 12% YoY
The operating income has contracted by 8% from the previous quarter
Price vs fundamentals
How does PFE's price correlate with its fundamentals
Growth
What is Pfizer's growth rate over time
Valuation
What is Pfizer stock price valuation
P/E
18.26
P/B
1.59
P/S
2.31
EV/EBIT
27.8
EV/EBITDA
14.37
EV/Sales
3.28
The price to earnings (P/E) is 8% lower than the 5-year quarterly average of 19.9
Pfizer's EPS has decreased by 2.1% from the previous quarter
PFE's P/B is 39% below its 5-year quarterly average of 2.6 and 6% below its last 4 quarters average of 1.7
Pfizer's equity has increased by 2.4% QoQ but it has decreased by 2.1% YoY
PFE's P/S is 30% below its 5-year quarterly average of 3.3 and 11% below its last 4 quarters average of 2.6
Pfizer's revenue has increased by 12% YoY
Efficiency
How efficient is Pfizer business performance
The company's return on invested capital fell by 7% QoQ
Pfizer's ROS has decreased by 6% from the previous quarter
Dividends
What is PFE's dividend history
DPS
$1.7
Dividend yield
6.7%
Payout ratio
122.3%
Recent dividends
Special dividends are included in TTM DPS and yield
Financial health
How did Pfizer financials performed over time
PFE's total assets is 77% greater than its total liabilities
The quick ratio has grown by 40% YoY and by 8% from the previous quarter
The current ratio has grown by 20% YoY and by 8% from the previous quarter
PFE's debt is 31% less than its equity
PFE's debt is down by 11% YoY and by 3.5% from the previous quarter
The debt to equity has contracted by 8% YoY and by 5% from the previous quarter
All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.